Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PRF TechnologiesPRFX -2.38%22 PS Ratio is 31.08 as of Sep. 09, 2026, which is 60% below its 10-year median of 77.31. GuruFocus rates PRFX with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 953 Drug Manufacturers companies, PRF Technologies ranks worse than 95.59% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, PRF Technologies's share price is $0.9324.
PRF Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.03. Hence, PRF Technologies's PS Ratio for today is 31.08.
Good Sign:
PRF Technologies Ltd stock PS Ratio (=37.23) is close to 1-year low of 36.81.
The historical rank and industry rank for PRF Technologies's PS Ratio or its related term are showing as below:
PRFX'
s PS Ratio Range Over the Past 10 Years
Min: 30.98 Med: 77.31 Max: 217.31
Current: 31.48
During the past 8 years, PRF Technologies's highest PS Ratio was 217.31. The lowest was 30.98. And the median was 77.31.
PRFX's PS Ratio is ranked worse than 95.59% of 953
companies
in the Drug Manufacturers industry
Industry Median: 2.38
vs PRFX: 31.48
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
PRF Technologies PS Ratio Related Terms
PRF Technologies PS Ratio Historical Data
* Premium members only.
The historical data trend for PRF Technologies's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, PRF Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PRF Technologies PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PRF Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where PRF Technologies's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
PRF Technologies's Share Price of today is $0.9324.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PRF Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PRF Technologies (PRFX) has a PS Ratio of 31.08 as of Sep. 09, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PRF Technologies and its competitors. This is 60% below median its historical median of 77.31. Over the past decade, PRF Technologies' PS Ratio has ranged from 30.98 to 217.31. According to the industry distribution chart, PRF Technologies ranks #911 out of 953 companies in the Drug Manufacturers industry, placing it in the top 95.6%.
Is PRF Technologies' PS Ratio too high?
PRF Technologies' current PS Ratio of 31.08 is 60% below median its 10-year median of 77.31. Over the past 10 years, this metric has ranged from a low of 30.98 to a high of 217.31. The Drug Manufacturers industry median PS Ratio is 2.38. PRF Technologies' value of 31.08 is 1205.9% above this industry median. Based on the distribution chart, PRF Technologies ranks #911 out of 953 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PRF Technologies has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does PRF Technologies' PS Ratio compare to CTTH and UPC?
According to the Drug Manufacturers industry distribution chart, PRF Technologies ranks #911 out of 953 companies for PS Ratio. This places PRF Technologies in the lower half of its industry. The industry median PS Ratio is 2.38. PRF Technologies' value of 31.08 is 1205.9% above this benchmark. Historically, PRF Technologies' own PS Ratio has ranged from 30.98 to 217.31 over the past decade. While the company's 10-year median is 77.31 vs. the industry median of 2.38, PRF Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Drug Manufacturers company?
The median PS Ratio among Drug Manufacturers companies is 2.38, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PRF Technologies's current PS Ratio of 31.08 is 1205.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PRF Technologies and its competitors. For the Drug Manufacturers industry, the median PS Ratio is 2.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PRF Technologies's current PS Ratio is 31.08, which is 60% below median its own 10-year median of 77.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PRF Technologies stock overvalued right now?
PRF Technologies (PRFX) has a current PS Ratio of 31.08. The current PS Ratio is 31.08, which is 60% below median its 10-year median of 77.31 and 1205.9% above the Drug Manufacturers industry median of 2.38. PRF Technologies' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For PRF Technologies (PRFX), the current PS Ratio is 31.08 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
22GF Score
Get the complete analysis for PRFX
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRFX has been successfully added to your 
